Numerous Journals Featuring CytexOrtho Technology

News

2024 OrthoPitch Winner!

2024 OrthoPitch Winner!

We’re super proud of our CEO, Brad Estes, Ph.D., as he impressed the audience and judges alike to lead CytexOrtho to victory at the first inaugural AAOS OrthoPitch competition! Our sincere thanks to MCRA and American Academy of Orthopaedic Surgeons (AAOS) for giving...

read more
AAOS OrthoPitch 2024

AAOS OrthoPitch 2024

CytexOrtho is excited to be selected as a finalist at the inaugural OrthoPitch contest next week at AAOS! CytexOrtho’s CEO, Dr. Brad Estes, will be battling it out with three other startups for the prizes and bragging rights at a brand-new technology competition for...

read more
Newsletter – January 2024

Newsletter – January 2024

The January 2024 issue of the CytexOrtho newsletter covers our 2023 accomplishments, including receiving Breakthrough Device Designation from the FDA, and highlights what is on the horizon in 2024: the plan for hosting our first clinical trial and the launch of our...

read more
Newsletter – June 2023

Newsletter – June 2023

The June issue of the CytexOrtho newsletter covers our successful crowdfunding raise, our progress toward clinical trials, and our talk on capitol hill! If you would like to receive a copy of our future newsletters, be sure to sign up for our mailing lists via the...

read more
CytexOrtho on Capital Hill

CytexOrtho on Capital Hill

On May 11th, 2023 Dr Brad Estes, CytexOrtho Co-founder and CEO, traveled to Washington D.C. to sit on a panel about the state of osteoarthritis (OA) in the United States, and the need for additional funding to move scientific advances combating OA to the clinic. The...

read more
Breakthrough Device Designation from the FDA

Breakthrough Device Designation from the FDA

  We are thrilled to announce that we just received a Breakthrough Device Designation from the United States Food and Drug Administration (FDA) for our novel hip cartilage repair technology. The intent of the Breakthrough Devices Program1 is to help patients have...

read more
October Newsletter

October Newsletter

The October issue of the CytexOrtho newsletter covers our progression toward clinical trials, discussions with the FDA, and our new CRP award from NIH! If you would like to receive a copy of our future newsletters, be sure to sign up for our mailing lists via the...

read more
In WRAL Techwire

In WRAL Techwire

CytexOrtho is in the news! WRAL Techwire featured a Startup Spotlight article about CytexOrtho on Monday, August 8th, 2022.  According to WRAL: “Startup Spotlight is a regular feature in WRAL Techwire, bringing attention to promising emerging companies across the...

read more
New Publication

New Publication

We are pleased to announce that our research is featured on the cover of the August 2022 issue of the Journal of Orthopaedic Research!   This review provides a summary of the research and development behind our osteochondral repair implant. The summary was the basis...

read more
June Newsletter

June Newsletter

The June issue of the CytexOrtho newsletter covers our progression toward clinical trials, discussions with the FDA, and our expanded presence on social media. If you would like to receive a copy of our future newsletters, be sure to sign up for our mailing lists via...

read more